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Abstract 
 
Background 
Capturing dimensions of physical activity relevant to patients may provide a unique 
perspective for clinical studies of chronically ill patients. However, the quality of the 
development of existing instruments is uncertain. The aim of this systematic review was to 
assess the development process of patient-reported outcome (PRO) instruments including 
their initial validation to measure physical activity in chronically ill or elderly patient 
populations.  
 
Methods 
We conducted a systematic literature search of electronic databases (Medline, Embase, 
Psychinfo, Cinahl) and hand searches. We included studies describing the original 
development of fully structured instruments measuring dimensions of physical activity or 
related constructs in chronically ills or elderly. We broadened the population to elderly 
because they are likely to share physical activity limitations. At least two reviewers 
independently conducted title and abstract screening and full text assessment. We evaluated 
instruments in terms of their aim, items identification and selection, domain development, 
test-retest reliability, internal consistency, validity and responsiveness. 
 
Results 
Of the 2542 references from the database search and 89 from the hand search, 103 full texts 
which covered 104 instruments met our inclusion criteria. For almost half of the instruments 
the authors clearly described the aim of the instruments before the scales were developed. For 
item identification, patient input was used in 38% of the instruments and in 32% adaptation of 
existing scales and/or unsystematic literature searches were the only sources for the 
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generation of items. For item reduction, in 56% of the instruments patient input was used and 
in 33% the item reduction process was not clearly described. Test-retest reliability was 
assessed for 61%, validity for 85% and responsiveness to change for 19% of the instruments. 
 
Conclusions 
Many PRO instruments exist to measure dimensions of physical activity in chronically ill and 
elderly patient populations, which reflects the relevance of this outcome. However, the 
development processes often lacked definitions of the instruments’ aims and patient input. If 
PROs for physical activity were to be used in clinical trials more attention needs to be paid to 
the establishment of content validity through patient input and to the assessment of their 
evaluative measurement properties. 
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Background 
Physical activity is crucial to chronically ill patients’ functioning in daily life. The 
evidence of the protective role of physical activity for the prevention and management of 
chronic diseases has been well established over recent decades [1, 2]. Physical activity is a 
multidimensional construct and defined as “any bodily movement produced by the 
contraction of skeletal muscle that increases energy expenditure above a basal level” [3].  
The assessment of physical activity as an outcome measure provides a unique 
perspective in chronic disease research not only for observational studies, but also for drug 
and nondrug clinical trials. Furthermore, evidence from trials regarding physical activity as a 
patient-reported outcome (PRO) could inform patients about treatment options that address 
relevant aspects of their daily life. Investigators who are interested in measuring physical 
activity face the challenge of not only choosing an instrument that serves their study aim, but 
that has also been carefully developed and validated. These instruments should have strong 
psychometric properties such as stability over time (test-retest reliability) and the capacity to 
detect even small effects (responsiveness to change). In addition, investigators need to be 
certain that the instruments reflect the dimensions of physical activity that are relevant to 
patients.  
It is currently unclear whether available instruments to measure physical activity fulfil 
these requirements. Therefore, the aim of this systematic review, which is part of the 
Innovative Medicines Initiative PROactive project (http://www.proactivecopd.com; a project 
jointly funded by the European Commission and the European Federation of Pharmaceutical 
Industries and Associations ‘EFPIA), was to identify existing fully structured PROs 
(questionnaires, scales) measuring physical activity (frequency, intensity and total amount), 
and/or symptoms (physical and mental) or complaints/concerns associated with physical 
activity in chronically ill or elderly patient populations. We broadened the population to 
elderly because they are likely to share some characteristics regarding physical activity with 
5 
chronically ill patients. Furthermore, the systematic review aimed to evaluate the 
methodological rigour with which the retrieved instruments were developed and initially 
validated as a part of the development process. Therefore, we restricted our review to the first 
validations of the instruments as part of the development process. In this paper we focused on 
the methods used in the development of the physical activity instruments. The content and the 
format of the included instruments are reviewed in another paper. 
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Methods 
A study protocol (unregistered) guided the entire review process. We followed standard 
systematic review methodology as outlined in the handbooks of the Centre for Reviews and 
Dissemination [4] and the Cochrane Collaboration. The reporting follows the PRISMA 
statement that recently replaced the former guidelines of reporting of systematic reviews and 
meta-analyses (QUOROM statement) [5].  
 
Eligibility criteria  
We considered the following criteria for inclusion and exclusion: 
Population  
We included PRO instruments developed for patients with chronic disease or elderly people. 
Elderly people were included because chronic illnesses usually affect people in later stages of 
life. In addition, we supplemented the electronic database search with explicit search terms for 
COPD patients. This is because this systematic review is part of the PROactive project, which 
aims to develop and validate two PRO instruments for COPD patients [6].  
Types of instrument  
We included fully structured instruments (scales or questionnaires) with standardised 
questions and answer options which were reported by the patient (self-reported). We only 
included interviewer administered instruments if the information was self-reported by the 
patient and we excluded instruments that required a rating by an interviewer.  
Content of instrument / assessment of physical activity  
We included instruments measuring dimensions of physical activity or related constructs. We 
considered the following definition for physical activity according to the U.S. Department of 
Health and Human Services [3]: “Physical activity is defined as any bodily movement 
produced by the contraction of skeletal muscle that increases energy expenditure above a 
basal level”. This definition of physical activity is broad and encompasses activities of daily 
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living, sports and activities for personal fulfilment. We did not restrict the search to 
instruments measuring the frequency, intensity and total amount of physical activity, but also 
considered instruments assessing “related constructs” and/or subscales that focused on 
symptoms (physical and mental) or complaints/concerns associated with physical activity. All 
of the instruments we included contained at least one physical activity subscale. We only 
included instruments whose items we could access from the publication or from the 
developers. We did not have any language or publication date restrictions. 
Study design  
We included both cross-sectional and longitudinal studies which described the development 
(including item generation, piloting etc) or modifications of the original instrument and the 
initial validation (psychometric properties, cross-sectional or longitudinal) of the original 
instrument. Since we focused on the methods used for the development process of the 
instruments, the article had to describe a minimum of the development or first validation 
process, for example, a description about item identification or selection and/or at least one 
assessment of test-retest, responsiveness or validity in a publication that was clearly the 
original. We excluded studies that used an eligible instrument as an outcome measure and 
were not designed to initially validate this instrument. We also excluded studies that reported 
the validation of instruments in additional languages and/or populations. 
 
Information sources 
Electronic database searches  
We searched the electronic databases Medline, Embase, PsycINFO and CINAHL on 
September 18th 2009. 
Hand searches 
We conducted the following hand searches to complement the electronic database search 
results: We searched for original development studies of instruments from articles which were 
excluded for the reason “validation only” or “used as outcome measures”; we scanned the 
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reference lists of the full texts; we searched the Patient-Reported Outcome and Quality of Life 
Instruments Database (PROQolid) on March 10 2010, search term: “physical functioning” 
questionnaires; and we contacted experts in the field and asked them to check if our list of 
included instruments was complete or if we missed any instruments. 
 
Search 
For the electronic database search, we used the following search terms: (physical activity OR 
functioning OR function OR motor activity OR activities of daily living OR walking OR 
activity OR exercise) AND (questionnaire* OR scale OR instrument OR tool OR diary OR 
assessment OR self-report OR measure*) AND (valid*) AND (chronic disease OR elderly 
OR COPD OR chronic lung disease OR chronic obstructive lung disease) NOT (athletic 
performance OR sports OR children OR adolescent). 
 
Study selection 
Title and abstract screening 
Two pairs of two reviewers each used a title and abstract screening document to 
independently review the title and abstract of every article retrieved by the database search. 
Decisions to include or exclude were recorded in the RefWorks-COS file (0 = exclude, 1 = 
order for full text assessment, 2 = only validation study of existing instrument, 3 = related 
study (e.g. reviews), do not order but may be useful reference). We ordered all articles that 
were deemed potentially eligible by at least one reviewer. 
Full text screening 
Two pairs of two reviewers each independently evaluated the full texts and made a decision 
on inclusion or exclusion according to the predefined selection criteria. They recorded their 
decision on a paper form together with the reason for exclusion (not relevant patient group; 
instrument does not measure dimensions of physical activity or related constructs; instrument 
is not self-reported (e.g. functional or exercise test like time to stand up from a chair or 6 
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minutes walking test); instrument with all its items is not available from the publication or 
from the developers; instrument is used as an outcome measure/study is not designed to 
validate this instrument, respectively; validation study only (e.g. additional languages, 
populations etc.); other). If the two reviewers could not agree, a third reviewer decided 
whether to include or exclude. Studies that did not fulfil all of the predefined criteria were 
excluded and their bibliographic details were listed with the specific reason for exclusion. 
Piloting the study selection process 
Initially, all reviewers piloted the selection process by applying the inclusion and exclusion 
criteria to the 50 first references for titles and abstracts screening and the first 30 papers for 
full text assessment. Inclusion and exclusion criteria were refined and clarified based on this 
piloting process. 
Dealing with lack of information 
We made three attempts to contact authors by e-mail in the following conditions: 1) If it was 
unclear from the full text article whether the study fulfilled the inclusion and exclusion 
criteria; 2) If the included development study lacked information on how the instrument was 
developed in order to complete data extraction; 3) If the included development study lacked 
information on the instrument’s content (items, introduction question, recall period etc.). If we 
failed to retrieve the relevant information from the author, this was reported on the data 
extraction form. 
Dealing with duplicate publications 
In cases where multiple papers were published (e.g. translations, reporting on different 
outcomes etc.), we treated the study with multiple reports as a single study but made reference 
to all publications. 
 
Data extraction process 
We created standardised data extraction forms based on a form used in a previous review [7] 
to record the relevant information from the articles. The data extraction forms were piloted 
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twice by four reviewers including 8 instruments for the first and 6 instruments for the second 
pilot. The forms and categories were then adapted and refined where necessary. The first 
reviewers extracted the data and stored it in a MS Word file. The second reviewers then 
independently extracted the data and compared their results with that of the first reviewers. 
These changes were made using the ‘track changes’ mode. The file was sent back to the first 
reviewer in order to come to an agreement. When an agreement could not be reached a third 
reviewer was consulted. 
 
Data extraction 
We extracted data from the development studies regarding the instruments’ development and 
initial validation process. We used pre-defined categories and answer options including 
numerical indications, fixed texts such as “yes/no”, multiple choice and free text. We 
extracted data for the following categories:  
 
Development of instruments 
Aim of instrument 
We distinguished between 3 categories: First, if the aim of the instrument was clearly 
described by the authors before the instrument was developed, the classification was 
“described”. We differentiated between the four aims “evaluative” (detection of changes over 
time, typically for evaluation of treatments), “discriminative” (detection of differences 
between patients, e.g. for phenotyping), “predictive” (prediction of future health outcomes, 
e.g. hospital admissions or death) and “planning” (planning of treatment, e.g. detection of 
areas with low scorings to target patient education accordingly). Second, if the aim was not 
explicitly described by the authors before development but could be identified from the 
context, the classification was "not clearly described, but presumably (e.g. evaluative)". Third, 
if the purpose of the instrument was not reported and could not be identified we used the 
classification "not described". 
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Identification of items 
To describe the identification of the items, we differentiated between five categories of 
sources of item generation (several answer options possible): patients and elderly (target 
population); experts (e.g. clinical experts, health professionals, care givers etc., also includes 
supplementation or modification of existing items through experts); significant others (e.g. 
family members, care givers); literature; and adaptation of existing instruments. We also 
described the method of item identification in brackets, for example, interviews or focus 
groups, systematic or unsystematic searches.  
 
Selection of items 
We reported the approach used by the authors to select items for the final instrument by 
differentiating between the following four sources: patients quantitative; patients qualitative; 
experts quantitative; experts qualitative. We provided specific details in brackets, for 
example, “Patients: quantitative (e.g. factor analysis)”, “Patients: qualitative (e.g. focus 
group)”, “Experts: quantitative (e.g. relevance)” or “Experts: qualitative (e.g. interviews)”.  
 
Development of domains 
We recorded the method of how the domains were defined, i.e. if they were defined a priori 
(the authors predefined domains and items which belong to these domains without statistical 
analyses but based on their clinical/research experience or opinion) or if domains were 
statistically defined by factor analysis. 
 
Initial validation of instruments 
Test-retest 
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We recorded if test-retest reliability (reproducibility) was examined and described the 
statistical method used, for example, intra-class correlation coefficients, coefficient of 
variation, Pearson or Spearman correlation coefficients or t-tests.  
 
Internal consistency 
We recorded if internal consistency reliability was assessed and described the statistical 
method used, for example, Cronbach’s alpha, corrected item total correlation or Cronbach’s 
alpha excluding item analysis.  
 
Validity 
We recorded if validity was assessed and if so, the type of validity that the authors described 
to assess (in quotation marks) and the statistical methods used (in brackets). 
 
Responsiveness 
We recorded any approaches to assess responsiveness (i.e. the ability of an instrument to 
detect changes over time) and we reported the statistical methods used. 
 
Minimal important difference (MID) 
We reported if the MID was examined and the statistical methods (e.g. anchor- or 
distribution-based approaches) used.  
 
Summary of conducted initial validation assessments according to aim of instrument 
The aim of the instrument determines the measurement properties, which should be assessed 
in the validation process. The assessment of test-retest reliability and internal consistency is 
important for each instrument development, regardless of whether the instrument’s aim is 
evaluative, discriminative, predictive or planning. For instruments with an evaluative aim, the 
longitudinal testing of the validity is of special interest whereas for instruments with 
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discriminative or planning aims, cross-sectional testing of the validity is sufficient. For 
instruments with evaluative aims, the assessment of responsiveness and the MID is crucial 
because they aim to detect changes over time.  
We summarised the assessed psychometric properties of the instruments for which the authors 
clearly described an aim before the instruments was developed.  
 
Synthesis of results 
We described the results of the data extraction in structured tables according to the categories 
described above (see Additional file 1). We synthesised the data on the instruments’ 
development and initial validation in a narrative way and in integrated tables. We used 
numbers and proportions to describe the results quantitatively. These frequencies were 
calculated using SPSS (Version 18.0).  
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Results 
 
Study selection 
Figure 1 shows the flow diagram of the identification of the studies. The electronic database 
search produced 2542 references. After title and abstract screening, 2268 of these were 
excluded resulting in 274 articles for full text assessment. This included 5 Japanese and one 
Chinese language article which were provisionally included due to their English abstract but 
were not included in the current analysis as we were unable to translate them [8-13]. Hand 
searches of reference sections and of excluded articles revealed an additional 70 
instruments/development studies for full text assessment. The search of the PROQolid 
database produced a further 58 instruments, 19 of which were included for full text 
assessment after title and abstract screening. One additional instrument was retrieved from the 
consultation with experts. Therefore, a total of 364 papers were included for full text 
assessment. 
Following full text assessment, a further 255 were excluded resulting in 104 instruments from 
103 full texts (the article of Mannerkorpi & Hernelid (2005) [14] provided information for the 
development process of two instruments) included in the review [14-117]. The most frequent 
reasons for exclusion were instrument is not self-reported (n = 71), followed by instrument 
does not measure physical activity (n = 66), validation study only (n = 35) and instrument 
used as an outcome measure (n = 29). The references of all excluded articles after full text 
assessment are summarised in Additional file 2.  
 
Study characteristics  
Additional file 1 summarises the extracted data for the development and initial validation 
process of the reviewed instruments.  
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Aim of instrument 
For almost half of the instruments (n = 49, 47.1%), the authors clearly described the aim of 
the instruments before the scales were developed. One aim was described for 26 instruments 
(53.1%) and more than one for 23 instruments (46.9%). The most frequently described aim 
was evaluative (n = 33), followed by discriminative (n = 26), planning (n = 13) and 
predictive (n = 5). For 43.3% of the instruments (n = 45), the authors did not clearly describe 
one or several aims but they could be presumed from the context (presumably discriminative: 
n = 32, presumably evaluative: n = 24, presumably planning: n = 9, presumably predictive: n 
= 9). For 10 instruments (9.6%), the authors did not describe an aim.  
 
Identification of items 
For 39 instruments (37.5%) items were identified with patient input, either with patient input 
only or with patient input together with other sources (adaptation of existing instruments, 
experts and/or literature). Adaptation of existing instruments and/or unsystematic literature 
searches only were the source for item identification of 33 instruments (31.7%), and expert 
input only or expert input additionally to literature and adaptation was the source for item 
identification of 14 instruments (13.5%). For the development of 18 instruments (17.3%), 
item identification was not reported or not clearly described. Table 1 describes the sources 
which were used to identify the items of the included instruments, ordered by frequency.  
The most frequently used method to generate patient input was “interviews with patients” 
only (for 24 of 39 instruments). Focus groups were less frequently conducted (for 5 of 39 
instruments) and for only 1 instrument both interviews and focus groups were conducted. For 
7 instruments, the method of generating patient input was not reported and for 2 instruments, 
patient input was described as “clinical interactions” or “open ended survey”. The methods 
used to obtain expert input were more diverse and varied from interviews with experts to 
workshops, ratings of relevance, unspecified discussions and undefined consideration of 
clinical opinion. Literature searches were always conducted unsystematically.  
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Selection of items 
For 58 instruments (55.8%), patient input was used for item reduction, and for 12 instruments 
(11.5%) the items were selected by expert input only. For 34 instruments (32.7%), item 
reduction was not clearly described (see Table 2). Where patient input was used for item 
selection (n = 58), the methods were predominantly quantitative (n = 31, 53.4%) and 
conducted by factor analysis (17 of 31 instruments). Less frequently used methods included 
item-total correlations, Rasch analyses and consideration of response rates and floor/ceiling 
effects. Qualitative methods, either alone or in addition to quantitative methods, were used in 
the selection of items for 46.6% (n = 27) of the instruments. Most frequently, qualitative 
patient input for item selection was generated by patient interviews (10 of 27 instruments). 
Less frequently focus groups and cognitive interviews/debriefings were used.  
 
Development of domains 
The domains were more often developed by factor analysis (n = 36, 34.6%) than by a priori 
specifications (n = 16, 15.4%). For half of the instruments, the development of the domains 
was not reported (n = 42, 40.4%) or was not applicable (n = 8, 7.7%). The domains of two 
instruments were developed by Rasch analysis. 
 
Test-retest 
Test-retest reliability was assessed for 63 instruments (60.6%). The most frequently used 
statistical methods were intraclass correlation coefficients either alone (n = 18) or together 
with other methods (n = 5). This was followed by Pearson correlation coefficient (n = 10), 
unspecified correlations (n = 9), various types of t-tests (either alone or together with other 
methods, n = 6) and various other methods (n = 15). 41 development studies (39.4%) did not 
report on assessing test-retest reliability.  
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Internal consistency 
Internal consistency was assessed in 62 development studies (59.6%). Most frequently 
internal consistency was assessed by Cronbach’s alpha alone (n = 46) or Cronbach’s alpha 
together with other methods (n = 10).  
 
Validity 
Eighty-eight studies reported on the assessment of validity (84.6%). The most frequently 
assessed type of validity that the authors described was construct validity (n = 43), followed 
by convergent/convergence validity (n = 19), discriminant validity (n = 18), concurrent 
validity (n = 16), content validity (n=12), criterion validity (n = 11), predictive validity (n = 
6), divergent validity (n = 4) and face validity (n = 4). For 25 instruments, the authors did not 
specify or name the type of validity tested. Most authors reported several types of validity. 
Validity was most frequently assessed with a correlational approach.  
 
Responsiveness 
The assessment of responsiveness was reported for 20 instruments only (19.2%). Several 
methods were used.  
 
MID 
Only 3 development studies reported on the MID (2.9%). 
 
Summary of initial validation assessments according to aim of instrument 
Table 3 refers to the instruments for which an aim was clearly described before the instrument 
was developed (n = 49, some studies described more than one aim). The table shows the 
number and percentage of instruments which assessed each psychometric property. The 
majority of instruments with a defined aim assessed validity in the initial validation process, 
regardless of the kind of aim, whereas test-retest was assessed for fewer instruments. For 
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40.6% of the instruments with an evaluative aim, responsiveness was assessed and the MID 
for 6.3%. 
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Discussion 
Our systematic review showed that there are many existing PRO instruments 
measuring various dimensions of physical activity, highlighting the importance of this 
concept as an outcome measure. The methodological quality of the development process 
varied considerably across the 104 included instruments. For the majority of the instruments, 
the aim either was not clearly described or not described at all before the instruments were 
developed. In addition, patients were often not involved in the item identification process of 
new instruments, making the adaptation of existing scales, unsystematic literature searches 
and/or expert input the only sources of item generation. Several instruments used quantitative 
patient input for item selection, but a surprisingly high number of studies did not describe or 
report on how items were selected. Also, the quality of the initial validation varied widely 
between the instruments. Internal consistency and test-retest reliability were assessed more 
frequently than responsiveness to change. The MID was estimated for only 3 instruments. 
Some instruments defined an evaluative aim; however, responsiveness was assessed in less 
than half of these. Many studies assessed construct validity while content validity was 
assessed for only a minority of the instruments.  
Over the last decades, physical activity instruments were traditionally used 
predominantly in epidemiological research to measure physical activity as a potential 
determinant of health outcomes [1, 2]. This requires that the instruments are able to 
discriminate between people in order to identify different levels of physical activity that might 
be associated with different health outcomes. In recent years, there has been growing interest 
in physical activity as a PRO measure. For example in obesity research, studies examine the 
effect of interventions on physical activity [118-120]. The use of physical activity instruments 
as outcome measures has implications for the development and initial validation process of 
these scales. Since PROs should be able to detect changes over time, their evaluative power is 
essential. Consequently, development and initial validation studies should go beyond cross-
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sectional studies and assess responsiveness to change and the MID in prospective follow-up 
studies [7].  
PROs for symptoms, health-related quality of life but also for physical activity have 
become a prevalent outcome in clinical trials. Over the last ten years many new PROs have 
been developed and validated and it can be expected that in the near future an increasing 
number of claims on the effectiveness of drugs will be made based on PROs. As a 
consequence, both the U.S. Food and Drug Administration (FDA) and the European 
Medicines Agency (EMA) have developed guidance documents on the requirements for PRO 
instruments that would allow making drug claims. A key evaluation point for the FDA is the 
evidence on content validity. Content validity describes the extent of how the instrument 
measures the concept of interest, which is specific to the population, condition and treatments 
to be studied. The FDA explicitly asks for patient input for item generation through 
qualitative research to ensure content validity in the development process of a new instrument 
[121-123].  
Although all of the PRO instruments included in this systematic review were 
developed before the finalisation of the FDA guidance document in December 2009, it is still 
surprising that in less than one third of the included studies authors reported on qualitative 
research for item generation such as patient interviews or focus groups, and a minority 
declared explicitly to have tested content validity of the newly developed instruments. These 
findings, along with the fact of poor reporting on item selection methods, indicate that only 
few physical activity PRO instruments would currently fulfil the FDA and EMA requirements 
for outcome measures. While the need to establish content validity has been recognised for 
many years, there has been little pressure to conduct qualitative research as illustrated in our 
systematic review. This is likely to change; at least in the field of clinical trials as 
investigators developing new instruments can now follow the FDA and EMA guidance to 
establish content validity more formally through qualitative research. Existing instruments are 
in a more difficult position, although they may in retrospect support their relevance to patients 
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through additional qualitative research. For example, one may examine whether the constructs 
measured by existing instruments align with what patients perceive to be important, or if 
important aspects are missing.  
One strength of this systematic review was the adherence to rigorous systematic 
review methodology along with the broad search strategy to identify existing physical activity 
instruments and subscales/domains. We supplemented the systematic database searches by a 
comprehensive hand search as well as by a PROQolid database search. As we aimed to 
identify any relevant instruments, we kept the inclusion criteria broad by using the definition 
for physical activity as described in the “2008 Physical activity guideline for Americans” [3]. 
Such a broad perspective could also be perceived as a limitation. Although we paid great 
attention to carefully defining the inclusion criteria, we cannot exclude the possibility of 
having missed questionnaires. Also, the decision about inclusion or exclusion of the 
instruments was sometimes ambiguous as for example for instruments assessing specific 
types of physical activity for chronic illnesses such as multiple sclerosis or chronic pain. In 
such cases we tried to adopt systematically and scientifically defendable decision criteria for 
inclusion or exclusion. For multiple sclerosis patients, for example, we did not consider 
physical activity instruments aiming at impaired hand motor activity but we included those 
assessing physical activity limitations which are more general and which could also be 
relevant for other chronic illnesses like “Walking ability” [54] or “Physical functioning” [93]. 
Another example includes activity limitations due to pain, where we excluded some 
instruments such as those targeting specialised pain coping activities, but included 
instruments such as the Activities of Daily Living Scale [71]. We focused solely on 
publications of the development and initial validation, which to some extent may 
underestimate the rigour of the overall development process. Undoubtedly some instruments 
might have had additional validation studies which we have not included in this review. 
However, we suspect that many instruments were introduced into research and practice rather 
rapidly without further validation, and, if validations were conducted during the development 
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process, it is likely that the authors would have published these results as part of the 
development paper.  
 
 
Conclusion 
Our systematic review showed that there are many existing PRO instruments 
measuring physical activity in chronically ill and elderly patient populations, highlighting the 
importance of this concept as an outcome measure. However, the development processes 
often lacked definitions of the instruments’ aims and patient input. If PROs for physical 
activity are to be used in clinical trials, there needs to be more focus on establishing content 
validity through patient input, and assessing their evaluative measurement properties. 
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Figure legends 
Figure 1. Flow diagram of identification of studies.  
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Tables 
 
Table 1. Sources of item identification of the included instruments (n = 104)1) 
Sources of item identification  n % 
Adaptation of existing scales only 18 17.3% 
Patients & experts & literature (unsystematic search)1) 13 12.5% 
Patients only 12 11.5% 
Literature only (unsystematic search) 10 9.6% 
Experts and literature (unsystematic search) 7 6.7% 
Patients and literature (unsystematic search) 6 5.8% 
Adaptation and literature (unsystematic search) 4 3.8% 
Patients and experts 4 3.8% 
Experts only 3 2.9% 
Experts and adaptation and literature (unsystematic search) 2 1.9% 
Patients and adaptation 2 1.9% 
Adaptation and literature (systematic search) 1 1% 
Adaptation and experts 1 1% 
Patients and adaptation and literature (unsystematic search) 1 1% 
Patients and experts and adaptation 1 1% 
Significant others and literature (unsystematic search) and adaptation 1 1% 
Not reported/not clearly described 18 17.3% 
1)
 For data extraction details, please see Additional file 1 
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Table 2. Source and method for item selection of the included instruments (n = 104)1) 
Source and method for item selection n %  n   % 
Selection with patient input   58 55.8% 
 Patients quantitative 21 20.2%   
 Patients qualitative 13 12.5%   
 Patients qualitative and quantitative 6 5.8%   
 Patients quantitative and experts qualitative 6 5.8%   
 Patients and experts qualitative 5 4.8%   
 Patients and experts quantitative 4 3.8%   
 Patients and experts qualitative, patients quantitative 3 2.9%   
Selection with expert input only  12 11.5% 
 Qualitative 5 4.8%   
 Quantitative 5 4.8%   
 Quantitative and qualitative 2 1.9%   
Not reported (n = 33) and N/A (n = 1)   34 32.7% 
1)
 For data extraction details, please see Additional file 1 
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Table 3. Conducted initial validation assessments according to described aims of 
instruments1) 
Described aim of 
instrument  
Test-retest Internal 
consistency 
Validity Responsivene
ss 
MID2) 
  n    %3) n    %3) n    %3) n    %3) n  %3) 
Evaluative (n=33) 23 69.7% 21 63.6% 32 96.9% 13 39.4% 2 6.1% 
Discriminative (n=26) 15 57.7% 18 69.2% 24 92.3% 6 23.1% 1 3.8% 
Planning (n=13) 11 84.6% 7 53.8% 12 92.3% 3 23.1% 1 7.7% 
Predictive (n=5) 1 20.0% 0   0% 3 60.0% 0   0% 0 0% 
1)
 For data extraction details, please see Additional file 1 
2)
 MID = Minimal important difference 
3)
 % in relation to the corresponding aim 
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Additional files 
 
Additional file 1 
Title: Data extraction results: Development and initial validation process of the reviewed 
instruments. 
Description: Summary of the extracted data for the development and initial validation process 
of the reviewed instruments according to the categories aim of instruments, identification of 
items, selection of items (item reduction), development of domains, test-retest, internal 
consistency, validity, responsiveness and MID.  
 
Additional file 2 
Title: References list of excluded articles after full text assessment. 
Description: List of all references of articles which have been excluded after full text 
assessment. 
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